/Storage Stable Formulations Of Sulfated Glycosaminoglycans And Fragments Derived Therefrom For The Treatment Of Pain And Other Medical Conditions
Abstract
One aspect of the present application relates to a storage stable pharmaceutical composition comprising a sulfated glycosaminoglycan having an average molecular weight ranging from 3,000 to 15,000 Daltons, and a pharmaceutical carrier, where the pharmaceutical carrier is mixed with the sulfated glycosaminoglycan, as well as this composition's use in a method of treating a subject for a medically observable improvement. Another aspect of the present application relates to a process for producing a storage stable purified sulfated glycosaminoglycan.
Full Text
What is claimed is:
One aspect of the present application relates to a storage stable pharmaceutical composition comprising a sulfated glycosaminoglycan having an average molecular weight ranging from 3,000 to 15,000 Daltons, and a pharmaceutical carrier, where the pharmaceutical carrier is mixed with the sulfated glycosaminoglycan, as well as this composition's use in a method of treating a subject for a medically observable improvement. Another aspect of the present application relates to a process for producing a storage stable purified sulfated glycosaminoglycan.
Timeline
Filed
04/30/2026Published
08/13/2026Granted
Not AvailableIPC Codes(6)
A61K 31/737:Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (takes precedence A61K 31/727)
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 9/06:Ointments; Bases therefor (apparatus for making A61J 3/04)